Compare POWL & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | POWL | ALKS |
|---|---|---|
| Founded | 1947 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 8.7B |
| IPO Year | 1995 | 2012 |
| Metric | POWL | ALKS |
|---|---|---|
| Price | $208.74 | $49.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 14 |
| Target Price | ★ $184.25 | $43.43 |
| AVG Volume (30 Days) | 819.2K | ★ 1.7M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.14% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.81 | N/A |
| Revenue | $448,716,000.00 | ★ $1,475,899,000.00 |
| Revenue This Year | $11.20 | $24.26 |
| Revenue Next Year | $9.12 | $4.47 |
| P/E Ratio | $54.48 | ★ N/A |
| Revenue Growth | ★ 13.34 | N/A |
| 52 Week Low | $178.05 | $25.17 |
| 52 Week High | $612.50 | $55.67 |
| Indicator | POWL | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 41.21 | 48.91 |
| Support Level | $181.33 | $47.66 |
| Resistance Level | $248.33 | $54.77 |
| Average True Range (ATR) | 14.39 | 1.88 |
| MACD | 1.39 | -0.39 |
| Stochastic Oscillator | 38.17 | 34.43 |
Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.